{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T15:09:19Z","timestamp":1794236959157,"version":"4.9.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070643"],"award-info":[{"award-number":["82070643"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.hbpd.2025.05.001","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T11:32:29Z","timestamp":1747999949000},"page":"643-655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["YBX1 is required for maintaining PD-L1 expression in intrahepatic cholangiocarcinoma by regulating STAT1 stability in an m5C-dependent manner"],"prefix":"10.1016","volume":"24","author":[{"given":"Xiang-Yi","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran-Ran","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan-Cheng","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2025.05.001_bib0001","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canlet.2015.09.008","article-title":"Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management","volume":"379","author":"Zhang","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0002","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"Razumilava","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0003","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaoncol.2019.3718","article-title":"Assessment of hepatic arterial infusion of floxuridine in combination with systemic gemcitabine and oxaliplatin in patients with unresectable intrahepatic cholangiocarcinoma: a phase 2 clinical trial","volume":"6","author":"Cercek","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0004","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.7150\/jca.17689","article-title":"Role of Y box protein-1 in cancer: as potential biomarker and novel therapeutic target","volume":"8","author":"Maurya","year":"2017","journal-title":"J Cancer"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejcb.2018.02.003","article-title":"YBX1 at the crossroads of non-coding transcriptome, exosomal, and cytoplasmic granular signaling","volume":"97","author":"Suresh","year":"2018","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0006","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41392-020-00375-5","article-title":"CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1","volume":"5","author":"Xu","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0007","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jhep.2021.08.027","article-title":"Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription","volume":"76","author":"Chen","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0008","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1093\/nar\/gkaa127","article-title":"Long noncoding RNA HCP5 participates in premature ovarian insufficiency by transcriptionally regulating MSH5 and DNA damage repair via YB1","volume":"48","author":"Wang","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0009","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13046-019-1493-4","article-title":"BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition","volume":"39","author":"Niu","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0010","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/cac2.12164","article-title":"YB1 regulates miR-205\/200b-ZEB1 axis by inhibiting microRNA maturation in hepatocellular carcinoma","volume":"41","author":"Liu","year":"2021","journal-title":"Cancer Commun (London)"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0011","doi-asserted-by":"crossref","first-page":"8314","DOI":"10.1038\/sj.onc.1208998","article-title":"Y-box factor YB1 controls p53 apoptotic function","volume":"24","author":"Homer","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0012","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1158\/2326-6066.CIR-18-0648","article-title":"Targeting the YB-1\/PD-L1 axis to enhance chemotherapy and antitumor immunity","volume":"7","author":"Tao","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0013","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41556-019-0361-y","article-title":"5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs","volume":"21","author":"Chen","year":"2019","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0014","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12943-022-01557-1","article-title":"LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer","volume":"21","author":"Shen","year":"2022","journal-title":"Mol Cancer"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0015","article-title":"Sustained complete remission on combination therapy with olaparib and pembrolizumab in BRCA2-mutated and PD-L1-positive metastatic cholangiocarcinoma after platinum derivate","volume":"12","author":"Zhou","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0016","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0017","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","article-title":"Cholangiocarcinoma - evolving concepts and therapeutic strategies","volume":"15","author":"Ilyas","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0018","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1158\/0008-5472.CAN-21-0468","article-title":"M6A demethylase ALKBH5 regulates PD-L1 expression and tumor immunoenvironment in intrahepatic cholangiocarcinoma","volume":"81","author":"Qiu","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0019","doi-asserted-by":"crossref","first-page":"7076","DOI":"10.3390\/ijms21197076","article-title":"YB-1 interferes with TNF\u03b1-TNFR binding and modulates progranulin-mediated inhibition of TNF\u03b1 signaling","volume":"21","author":"Hessman","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.kint.2019.09.031","article-title":"The YB-1:Notch-3 axis modulates immune cell responses and organ damage in systemic lupus erythematosus","volume":"97","author":"Breitkopf","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0021","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/OTT.S288982","article-title":"Clinicopathological and prognostic significance of immunoscore and PD-L1 in intrahepatic cholangiocarcinoma","volume":"14","author":"Wu","year":"2021","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0022","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s12935-021-02081-w","article-title":"Relationship between PD-L1 expression, CD8+ T-cell infiltration and prognosis in intrahepatic cholangiocarcinoma patients","volume":"21","author":"Deng","year":"2021","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0023","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0024","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1038\/s41388-021-01978-0","article-title":"NSUN2-mediated RNA 5-methylcytosine promotes esophageal squamous cell carcinoma progression via LIN28B-dependent GRB2 mRNA stabilization","volume":"40","author":"Su","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.celrep.2013.06.029","article-title":"NSun2-mediated cytosine-5 methylation of vault noncoding RNA determines its processing into regulatory small RNAs","volume":"4","author":"Hussain","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0026","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/cr.2017.55","article-title":"5-methylcytosine promotes mRNA export - NSUN2 as the methyltransferase and ALYREF as an m5C reader","volume":"27","author":"Yang","year":"2017","journal-title":"Cell Res"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0027","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/s41591-018-0217-1","article-title":"Translational control of tumor immune escape via the eIF4F-STAT1-PD-L1 axis in melanoma","volume":"24","author":"Cerezo","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0028","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41419-021-04127-3","article-title":"NSUN2 modified by SUMO-2\/3 promotes gastric cancer progression and regulates mRNA m5C methylation","volume":"12","author":"Hu","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0029","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3390\/cells9081758","article-title":"The RNA methyltransferase NSUN2 and its potential roles in cancer","volume":"9","author":"Chellamuthu","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0030","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41420-023-01521-y","article-title":"NSUN2 stimulates tumor progression via enhancing TIAM2 mRNA stability in pancreatic cancer","volume":"9","author":"Zhang","year":"2023","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0031","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1158\/0008-5472.CAN-09-3155","article-title":"Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance","volume":"70","author":"To","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0032","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood.2020009676","article-title":"YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner","volume":"138","author":"Feng","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0033","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/s41418-021-00920-x","article-title":"YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer","volume":"29","author":"Jiang","year":"2022","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0034","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12943-018-0928-4","article-title":"Role of the tumor microenvironment in PD-L1\/PD-1-mediated tumor immune escape","volume":"18","author":"Jiang","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0035","doi-asserted-by":"crossref","first-page":"51210","DOI":"10.18632\/oncotarget.17214","article-title":"PD-1 and PD-L1 expression in 132 recurrent nasopharyngeal carcinoma: the correlation with anemia and outcomes","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142656","article-title":"High PD-L1 expression correlates with metastasis and poor prognosis in oral squamous cell carcinoma","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0037","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/his.13238","article-title":"PD-L1 expression in extrahepatic cholangiocarcinoma","volume":"71","author":"Walter","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0038","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","article-title":"Regulation and function of the PD-L1 checkpoint","volume":"48","author":"Sun","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0039","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1593\/neo.05733","article-title":"The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors","volume":"8","author":"Ghebeh","year":"2006","journal-title":"Neoplasia"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0040","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1158\/0008-5472.CAN-05-4303","article-title":"Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up","volume":"66","author":"Thompson","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0041","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1158\/1078-0432.CCR-06-2746","article-title":"Clinical significance and therapeutic potential of the programmed death-1 ligand\/programmed death-1 pathway in human pancreatic cancer","volume":"13","author":"Nomi","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0042","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-18132-0","article-title":"IFN\u03b3 induces PD-L1 overexpression by JAK2\/STAT1\/IRF-1 signaling in EBV-positive gastric carcinoma","volume":"7","author":"Moon","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0043","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13046-020-01687-8","article-title":"LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p\/STAT1\/PD-L1 axis","volume":"39","author":"Zhang","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.hbpd.2025.05.001_bib0044","doi-asserted-by":"crossref","first-page":"691","DOI":"10.7150\/ijbs.79205","article-title":"Upregulation of LRRC8A by m5C modification-mediated mRNA stability suppresses apoptosis and facilitates tumorigenesis in cervical cancer","volume":"19","author":"Chen","year":"2023","journal-title":"Int J Biol Sci"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387225000906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387225000906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T11:28:21Z","timestamp":1768476501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387225000906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1499387225000906"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2025.05.001","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"YBX1 is required for maintaining PD-L1 expression in intrahepatic cholangiocarcinoma by regulating STAT1 stability in an m5C-dependent manner","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2025.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}